MetLife Investment Management’s Babcock & Wilcox BW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-31,760
Closed -$134K 2832
2023
Q3
$134K Hold
31,760
﹤0.01% 2431
2023
Q2
$187K Hold
31,760
﹤0.01% 2317
2023
Q1
$192K Buy
31,760
+7,920
+33% +$48.9K ﹤0.01% 2247
2022
Q4
$138K Sell
23,840
-7,762
-25% -$42.4K ﹤0.01% 2456
2022
Q3
$202K Buy
31,602
+6,336
+25% +$47.1K ﹤0.01% 2297
2022
Q2
$152K Buy
25,266
+3,333
+15% +$23.3K ﹤0.01% 2484
2022
Q1
$179K Buy
21,933
+2,305
+12% +$18K ﹤0.01% 2416
2021
Q4
$177K Buy
19,628
+11,806
+151% +$94.6K ﹤0.01% 2126
2021
Q3
$50.1K Sell
7,822
-13,352
-63% -$93.2K ﹤0.01% 2533
2021
Q2
$167K Buy
+21,174
New +$175K ﹤0.01% 2264
2018
Q1
Sell
-2,258
Closed -$128K 2202
2017
Q4
$128K Buy
+2,258
New +$102K ﹤0.01% 2144

Other funds holding BW

MetLife Investment Management's BW Position: Q4 2023 in Review

MetLife Investment Management sold out of Babcock & Wilcox (BW) in Q4 2023, closing a stake of 31,760 shares — an estimated $134K sold.

MetLife Investment Management first reported a position in BW in Q4 2017 and held it in 11 quarters. The position peaked at $202K in Q3 2022. 103 funds tracked by Wall St. Rank hold BW as of Q4 2023.

  • MetLife Investment Management reported no remaining Babcock & Wilcox position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 31,760 Babcock & Wilcox shares in Q4 2023, an estimated $134K.
  • MetLife Investment Management first reported a position in Babcock & Wilcox in Q4 2017 and held it in 11 quarters.
  • MetLife Investment Management's Babcock & Wilcox position peaked at $202K in Q3 2022.
  • 103 funds tracked by Wall St. Rank held Babcock & Wilcox as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.